Elevated NRF2 enhanced the growth and motility of breast cancer cells by upregulating a pivotal enzyme of the pentose phosphate pathway, i.e., the glucose-6-phosphate dehydrogenase (G6PD) (195). This evidence concerns the gene G6PD and breast carcinoma.